Ricin Toxoid for Prophylactic Vaccine Trials from Japan
Detoxified ricin toxoid used in phase I/II vaccine trials for inducing immunity against ricin exposure. Fits HTS 3002.49.0010 as a toxin for prophylactic uses in clinical settings. Developed for military and civilian biodefense.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Submit IND application details and trial protocol to justify prophylactic classification
• Use validated cold chain with data loggers; pitfall is thermal excursion claims denial
• Declare as 'clinical trial toxin' to differentiate from research grade